Long‐term clinical safety of Clindamycin and Rifampicin combination for the treatment of Hidradenitis Suppurativa: strategy to reduce side effects, improving patients’ compliance

Abstract

We read with great interest the article by Albrecht et al.¹ regarding the long‐term clinical safety of Clindamycin and Rifampicin combination for the treatment of Hidradenitis Suppurativa (HS).

The authors discuss carefully whether Clindamycin and Rifampicin could be safely continued beyond a 10 week course, analyzing long term toxicity of these drugs.

This article is protected by copyright. All rights reserved.

https://ift.tt/2QJSOr0